🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/10/1998 | 41,17 | 42,58 | 38,83 | 38,83 | -5,68% | 9,09% | 128.480 |
| 26/10/1998 | 40,24 | 41,17 | 40,00 | 41,17 | +4,76% | 2,91% | 71.093 |
| 23/10/1998 | 40,24 | 40,24 | 38,60 | 39,30 | +0,00% | 4,07% | 55.945 |
| 22/10/1998 | 37,43 | 39,54 | 36,96 | 39,30 | +7,01% | 6,88% | 71.387 |
| 21/10/1998 | 36,03 | 37,43 | 36,03 | 36,73 | +3,29% | 3,90% | 33.850 |
| 20/10/1998 | 35,44 | 37,43 | 33,92 | 35,56 | +3,40% | 9,90% | 100.000 |
| 19/10/1998 | 29,94 | 34,86 | 29,48 | 34,39 | +13,95% | 17,97% | 77.452 |
| 16/10/1998 | 29,01 | 30,41 | 28,77 | 30,18 | +5,74% | 5,64% | 40.556 |
| 15/10/1998 | 29,01 | 29,01 | 27,84 | 28,54 | -1,61% | 4,03% | 19.316 |
| 14/10/1998 | 27,14 | 29,01 | 26,67 | 29,01 | +6,90% | 8,62% | 38.071 |
| 13/10/1998 | 29,94 | 30,18 | 27,14 | 27,14 | -7,94% | 10,16% | 43.602 |
| 12/10/1998 | 29,48 | 32,05 | 29,48 | 29,48 | +2,44% | 8,73% | 73.311 |
| 09/10/1998 | 27,14 | 29,01 | 27,14 | 28,77 | +5,13% | 6,90% | 62.410 |
| 08/10/1998 | 27,60 | 28,31 | 25,97 | 27,37 | -2,50% | 8,47% | 78.654 |
| 07/10/1998 | 33,22 | 34,39 | 28,07 | 28,07 | -16,67% | 19,01% | 64.040 |
| 06/10/1998 | 35,09 | 36,03 | 32,75 | 33,69 | -2,70% | 9,33% | 46.808 |
| 05/10/1998 | 35,09 | 35,32 | 34,15 | 34,62 | -4,52% | 3,33% | 84.291 |
| 02/10/1998 | 35,09 | 36,49 | 33,92 | 36,26 | +4,03% | 7,33% | 49.666 |
| 01/10/1998 | 33,69 | 37,66 | 33,22 | 34,86 | +2,05% | 13,19% | 80.738 |
| 30/09/1998 | 42,11 | 42,11 | 33,69 | 34,15 | -17,05% | 20,00% | 127.278 |
| 29/09/1998 | 43,51 | 46,32 | 40,24 | 41,17 | -4,35% | 13,98% | 270.640 |
| 28/09/1998 | 37,90 | 43,04 | 37,43 | 43,04 | +14,29% | 14,81% | 88.031 |
| 25/09/1998 | 39,07 | 39,07 | 36,49 | 37,66 | -4,17% | 6,59% | 89.715 |
| 24/09/1998 | 38,37 | 42,11 | 38,13 | 39,30 | +3,70% | 10,37% | 157.388 |
| 23/09/1998 | 34,62 | 38,13 | 34,62 | 37,90 | +12,50% | 10,13% | 155.037 |
| 22/09/1998 | 32,28 | 34,15 | 31,46 | 33,69 | +16,13% | 8,33% | 150.629 |
| 21/09/1998 | 26,67 | 29,48 | 25,73 | 29,01 | +8,77% | 14,04% | 78.173 |
| 18/09/1998 | 27,14 | 27,14 | 25,97 | 26,67 | +0,88% | 4,31% | 117.580 |
| 17/09/1998 | 24,33 | 27,14 | 24,33 | 26,43 | +1,80% | 11,54% | 93.588 |
| 16/09/1998 | 26,20 | 26,43 | 25,27 | 25,97 | -0,89% | 4,46% | 53.487 |